Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionchromatin binding

SMARCA2 PELP1 POLR3GL SUPT5H SUPT6H POLR3G

8.48e-05739216GO:0003682
GeneOntologyBiologicalProcesstranscription elongation-coupled chromatin remodeling

SUPT5H SUPT6H

4.42e-0510212GO:0140673
GeneOntologyCellularComponentRNA polymerase III complex

POLR3GL POLR3G

1.46e-0418212GO:0005666
GeneOntologyCellularComponentnuclear DNA-directed RNA polymerase complex

POLR3GL GTF2A1 POLR3G

1.91e-04113213GO:0055029
GeneOntologyCellularComponentDNA-directed RNA polymerase complex

POLR3GL GTF2A1 POLR3G

2.06e-04116213GO:0000428
GeneOntologyCellularComponentRNA polymerase complex

POLR3GL GTF2A1 POLR3G

2.22e-04119213GO:0030880
GeneOntologyCellularComponentnuclear protein-containing complex

SMARCA2 PELP1 POLR3GL SUPT5H GTF2A1 SUPT6H POLR3G

2.71e-041377217GO:0140513
GeneOntologyCellularComponenttranscription elongation factor complex

SUPT5H SUPT6H

1.43e-0356212GO:0008023
GeneOntologyCellularComponenttransferase complex, transferring phosphorus-containing groups

POLR3GL GTF2A1 POLR3G

4.38e-03335213GO:0061695
DomainRNA_pol_III_Rpc31

POLR3GL POLR3G

1.20e-062212IPR024661
DomainRNA_pol_3_Rpc31

POLR3GL POLR3G

1.20e-062212PF11705
DomainBBOX

TRIM52 TRIM41

2.70e-0369212SM00336
Domain-

TRIM52 TRIM41

2.86e-03712124.10.45.10
Domainzf-B_box

TRIM52 TRIM41

2.94e-0372212PF00643
DomainZF_BBOX

TRIM52 TRIM41

3.61e-0380212PS50119
DomainZnf_B-box

TRIM52 TRIM41

3.70e-0381212IPR000315
PathwayREACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS

SUPT5H GTF2A1 SUPT6H

6.36e-0581143M865
PathwayREACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS

SUPT5H GTF2A1 SUPT6H

6.84e-0583143MM15314
PathwayREACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION

POLR3GL POLR3G

1.39e-0418142M1055
PathwayREACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION

POLR3GL POLR3G

2.29e-0423142M1024
PathwayREACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER

POLR3GL POLR3G

2.94e-0426142MM15458
PathwayBIOCARTA_CARM_ER_PATHWAY

PELP1 GTF2A1

2.94e-0426142M2499
PathwayREACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER

POLR3GL POLR3G

3.17e-0427142MM15457
PathwayREACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER

POLR3GL POLR3G

3.41e-0428142M1022
PathwayREACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER

POLR3GL POLR3G

3.41e-0428142M27716
PathwayKEGG_RNA_POLYMERASE

POLR3GL POLR3G

3.66e-0429142M1724
PathwayREACTOME_RNA_POLYMERASE_III_TRANSCRIPTION

POLR3GL POLR3G

5.05e-0434142MM15435
PathwayREACTOME_RNA_POLYMERASE_III_TRANSCRIPTION

POLR3GL POLR3G

7.35e-0441142M739
PathwayKEGG_CYTOSOLIC_DNA_SENSING_PATHWAY

POLR3GL POLR3G

1.32e-0355142M11844
PathwayREACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX

SUPT5H SUPT6H

1.47e-0358142M805
PathwayREACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX

SUPT5H SUPT6H

1.52e-0359142MM14504
PathwayWP_TAR_SYNDROME

POLR3GL POLR3G

1.73e-0363142M48082
PathwayREACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA

POLR3GL POLR3G

1.78e-0364142M27046
PathwayREACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME

SUPT5H GTF2A1

2.13e-0370142M27008
PathwayREACTOME_GENE_EXPRESSION_TRANSCRIPTION

POLR3GL SUPT5H GTF2A1 SUPT6H POLR3G

2.28e-031022145MM15436
PathwayREACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES

SUPT5H GTF2A1

2.31e-0373142MM15349
PathwayWP_CYTOSOLIC_DNASENSING_PATHWAY

POLR3GL POLR3G

2.31e-0373142M39837
PathwayREACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES

SUPT5H GTF2A1

2.84e-0381142M27647
PathwayWP_PYRIMIDINE_METABOLISM

POLR3GL POLR3G

3.05e-0384142M48340
PathwayKEGG_PYRIMIDINE_METABOLISM

POLR3GL POLR3G

4.12e-0398142M5109
Pubmed

Effects on prostate cancer cells of targeting RNA polymerase III.

POLR3GL POLR3G

3.47e-07221230820548
Pubmed

Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation.

SUPT5H SUPT6H

3.47e-0722129514752
Pubmed

Structure of activated transcription complex Pol II-DSIF-PAF-SPT6.

SUPT5H SUPT6H

3.47e-07221230135578
Pubmed

Functions of paralogous RNA polymerase III subunits POLR3G and POLR3GL in mouse development.

POLR3GL POLR3G

3.47e-07221232576691
Pubmed

Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.

PELP1 YTHDC1 SUPT5H SUPT6H APLP2

3.48e-0725121528077445
Pubmed

Human Spt6 stimulates transcription elongation by RNA polymerase II in vitro.

SUPT5H SUPT6H

1.04e-06321215060154
Pubmed

Structure-function analysis of hRPC62 provides insights into RNA polymerase III transcription initiation.

POLR3GL POLR3G

2.08e-06421221358628
Pubmed

Two isoforms of human RNA polymerase III with specific functions in cell growth and transformation.

POLR3GL POLR3G

3.47e-06521220154270
Pubmed

Isolation of murine SPT5 homologue: completion of the isolation and characterization of human and murine homologues of yeast chromatin structural protein complex SPT4, SPT5, and SPT6.

SUPT5H SUPT6H

5.20e-0662129480761
Pubmed

Gene duplication and neofunctionalization: POLR3G and POLR3GL.

POLR3GL POLR3G

1.25e-05921224107381
Pubmed

Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.

YTHDC1 CREBRF GTF2A1 CEP152 POLR3G

1.42e-0553621515840001
Pubmed

Exchangeable gene trap using the Cre/mutated lox system.

YTHDC1 CREBRF GTF2A1 CEP152 POLR3G

1.44e-0553821510512203
Pubmed

Targeting HIV transcription: the quest for a functional cure.

SMARCA2 SUPT5H

1.90e-051121225731772
Pubmed

De novo phosphorylation of H2AX by WSTF regulates transcription-coupled homologous recombination repair.

SUPT5H SUPT6H

1.90e-051121231045206
Pubmed

Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma.

SUPT5H SUPT6H

4.70e-051721236352191
Pubmed

ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.

PELP1 SUPT5H SUPT6H

9.88e-0515021328242625
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

PELP1 GTF2A1 SPTY2D1

1.03e-0415221338360978
Pubmed

Elongin A regulates transcription in vivo through enhanced RNA polymerase processivity.

SUPT5H SUPT6H

1.12e-042621233298525
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

SMARCA2 PELP1 SUPT5H SUPT6H

1.28e-0444021434244565
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

PELP1 YTHDC1 SUPT5H SUPT6H

1.63e-0446921427634302
Pubmed

Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.

YTHDC1 POLR3GL SUPT5H GTF2A1 TRIM41 STAC3

1.82e-04147721631515488
Pubmed

A RECQ5-RNA polymerase II association identified by targeted proteomic analysis of human chromatin.

SUPT5H SUPT6H

2.28e-043721218562274
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

PELP1 YTHDC1 SUPT5H SUPT6H SPTY2D1

2.56e-0498921536424410
Pubmed

Phosphoproteome analysis of the human mitotic spindle.

PELP1 YTHDC1 TRIM41

2.66e-0421021316565220
Pubmed

Protein interaction studies in human induced neurons indicate convergent biology underlying autism spectrum disorders.

SMARCA2 STAC3

3.09e-044321236950384
Pubmed

Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.

SUPT5H SUPT6H SPTY2D1

3.13e-0422221337071664
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

ZNF330 SUPT5H APLP2 MICAL3 CSPG5

3.36e-04104921527880917
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

SMARCA2 PELP1 SUPT5H SUPT6H

4.29e-0460521428977666
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

SMARCA2 PELP1 SUPT5H SUPT6H

5.72e-0465321422586326
Pubmed

ELOF1 is a transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation.

SUPT5H SUPT6H

5.82e-045921234108663
InteractionPOLR3E interactions

POLR3GL SUPT6H TRIM52 POLR3G

3.46e-06102214int:POLR3E
InteractionSLC35G1 interactions

SMARCA2 SUPT5H SUPT6H

5.72e-0634213int:SLC35G1
InteractionIWS1 interactions

YTHDC1 ZNF330 SUPT5H SUPT6H

5.78e-06116214int:IWS1
InteractionTAF1 interactions

SMARCA2 PELP1 YTHDC1 ZNF330 GTF2A1

5.91e-06260215int:TAF1
InteractionPOLR2F interactions

POLR3GL SUPT5H SUPT6H POLR3G

1.36e-05144214int:POLR2F
InteractionGTF2E1 interactions

SMARCA2 YTHDC1 ZNF330 GTF2A1

1.36e-05144214int:GTF2E1
InteractionPOLR2K interactions

POLR3GL SUPT5H SUPT6H POLR3G

1.82e-05155214int:POLR2K
InteractionPOLR3A interactions

YTHDC1 POLR3GL TRIM52 POLR3G

2.22e-05163214int:POLR3A
InteractionPOLR2L interactions

POLR3GL SUPT5H SUPT6H POLR3G

2.74e-05172214int:POLR2L
InteractionPYHIN1 interactions

PELP1 YTHDC1 SUPT5H SUPT6H APLP2

2.77e-05358215int:PYHIN1
InteractionSUPT4H1 interactions

SMARCA2 SUPT5H SUPT6H

4.48e-0567213int:SUPT4H1
InteractionBAZ1B interactions

SMARCA2 ZNF330 SUPT5H SUPT6H

5.33e-05204214int:BAZ1B
InteractionCCDC71 interactions

YTHDC1 SUPT5H SUPT6H

5.55e-0572213int:CCDC71
InteractionPOLR2H interactions

POLR3GL SUPT5H SUPT6H POLR3G

7.53e-05223214int:POLR2H
InteractionZNF330 interactions

YTHDC1 ZNF330 SUPT5H SUPT6H SPTY2D1

7.88e-05446215int:ZNF330
InteractionCTR9 interactions

ZNF330 SUPT5H SUPT6H TRIM52

8.93e-05233214int:CTR9
InteractionGTF2F1 interactions

SMARCA2 ZNF330 GTF2A1 STAC3

9.08e-05234214int:GTF2F1
InteractionEYA4 interactions

PELP1 SUPT5H GTF2A1 SPTY2D1

1.05e-04243214int:EYA4
InteractionVAX2 interactions

SMARCA2 GTF2A1

1.08e-0415212int:VAX2
InteractionDHX40 interactions

YTHDC1 SUPT5H SUPT6H TRIM52

1.15e-04249214int:DHX40
InteractionZNF138 interactions

YTHDC1 TRIM41

1.75e-0419212int:ZNF138
InteractionTASOR interactions

YTHDC1 SUPT5H TRIM52

1.96e-04110213int:TASOR
InteractionCOIL interactions

YTHDC1 ZNF330 SUPT5H SUPT6H SPTY2D1

2.14e-04552215int:COIL
InteractionRECQL5 interactions

ZNF330 SUPT5H SUPT6H

2.18e-04114213int:RECQL5
InteractionNSD3 interactions

SMARCA2 ZNF330 STAC3

2.35e-04117213int:NSD3
InteractionZNF275 interactions

YTHDC1 TRIM41

2.58e-0423212int:ZNF275
InteractionPOLR2E interactions

POLR3GL SUPT5H SUPT6H POLR3G

2.61e-04308214int:POLR2E
InteractionH3C8 interactions

SUPT6H SPTY2D1

3.57e-0427212int:H3C8
InteractionZNF587 interactions

YTHDC1 ZNF330 TRIM41

3.58e-04135213int:ZNF587
InteractionSCAF4 interactions

SUPT5H SUPT6H SPTY2D1

4.07e-04141213int:SCAF4
InteractionPIGF interactions

SUPT5H SUPT6H

4.13e-0429212int:PIGF
InteractionSNRNP40 interactions

PELP1 YTHDC1 SUPT5H SUPT6H SPTY2D1

4.15e-04637215int:SNRNP40
InteractionURI1 interactions

SUPT6H TRIM52 PLCE1

4.24e-04143213int:URI1
InteractionTCF20 interactions

YTHDC1 ZNF330 SUPT5H

4.50e-04146213int:TCF20
InteractionPOLR2J interactions

SUPT5H SUPT6H TRIM52

5.06e-04152213int:POLR2J
InteractionPOLR3G interactions

POLR3GL POLR3G

5.36e-0433212int:POLR3G
InteractionSLU7 interactions

ZNF330 SUPT5H SUPT6H

5.46e-04156213int:SLU7
InteractionNCBP3 interactions

ZNF330 SUPT5H MICAL3

5.46e-04156213int:NCBP3
InteractionSSRP1 interactions

YTHDC1 ZNF330 SUPT5H SUPT6H SPTY2D1

5.78e-04685215int:SSRP1
InteractionTOP1 interactions

YTHDC1 ZNF330 SUPT5H SUPT6H SPTY2D1

6.22e-04696215int:TOP1
InteractionRAD51AP1 interactions

SMARCA2 ZNF330

6.38e-0436212int:RAD51AP1
InteractionSETD5 interactions

YTHDC1 SUPT5H

6.74e-0437212int:SETD5
InteractionH3C10 interactions

SUPT5H SUPT6H

7.11e-0438212int:H3C10
InteractionSUSD1 interactions

YTHDC1 GPIHBP1

7.11e-0438212int:SUSD1
InteractionSRPK2 interactions

PELP1 YTHDC1 ZNF330 SUPT6H TRIM41

7.12e-04717215int:SRPK2
InteractionPOLR3GL interactions

POLR3GL POLR3G

7.49e-0439212int:POLR3GL
InteractionH2AC8 interactions

PELP1 SPTY2D1 TRIM41

7.88e-04177213int:H2AC8
InteractionH2BC1 interactions

SMARCA2 PELP1 TRIM41

8.01e-04178213int:H2BC1
InteractionPPP1R10 interactions

YTHDC1 SUPT5H SPTY2D1

8.15e-04179213int:PPP1R10
InteractionZNF655 interactions

ZNF330 SUPT5H TRIM41

8.41e-04181213int:ZNF655
InteractionRNPS1 interactions

YTHDC1 SUPT5H SUPT6H TRIM41

8.78e-04425214int:RNPS1
InteractionCHD3 interactions

SMARCA2 PELP1 ZNF330 SUPT5H SUPT6H

9.09e-04757215int:CHD3
InteractionH3C12 interactions

SUPT6H SPTY2D1

9.10e-0443212int:H3C12
InteractionZNF644 interactions

YTHDC1 ZNF330 TRIM52

9.10e-04186213int:ZNF644
InteractionCEP43 interactions

SUPT5H TRIM52 CEP152

9.68e-04190213int:CEP43
InteractionNOG interactions

APLP2 CSPG5

9.97e-0445212int:NOG
InteractionSUPT16H interactions

SMARCA2 ZNF330 SUPT5H SUPT6H

1.02e-03442214int:SUPT16H
InteractionZNF324 interactions

YTHDC1 TRIM52

1.04e-0346212int:ZNF324
InteractionFAM124A interactions

TRIM41 STAC3

1.04e-0346212int:FAM124A
InteractionZNF512B interactions

ZNF330 SUPT5H APLP2

1.06e-03196213int:ZNF512B
InteractionZFP64 interactions

GTF2A1 TRIM41

1.18e-0349212int:ZFP64
CytobandEnsembl 112 genes in cytogenetic band chr5q35

CREBRF TRIM52 TRIM41

1.65e-04235213chr5q35
Cytoband5q35.3

TRIM52 TRIM41

8.67e-04952125q35.3
GeneFamilyRing finger proteins|Tripartite motif containing|ARF GTPase family

TRIM52 TRIM41

1.20e-039510259
GeneFamilyRing finger proteins

TRIM52 TRIM41

9.57e-0327510258
DrugFlorfenicol [73231-34-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A

SMARCA2 ZNF330 CSPG5 POLR3G

2.90e-051972145300_DN
DrugCisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A

SUPT5H SUPT6H MICAL3 POLR3G

2.96e-051982143305_DN
DrugEsculetin [305-01-1]; Down 200; 22.4uM; MCF7; HT_HG-U133A

SMARCA2 SUPT6H CEP152 POLR3G

3.08e-052002147459_DN
DrugUTP-NA

POLR3GL SUPT5H GTF2A1 PLCE1 POLR3G

3.33e-05420215CID000001181
DrugNSC20261

POLR3GL SUPT5H GTF2A1 POLR3G

4.79e-05224214CID000000593
DrugS-150

GTF2A1 POLR3G

2.03e-0423212CID000069432
Drugbufotenine

SUPT5H SUPT6H

2.80e-0427212CID000010257
DrugAC1L1YB5

SMARCA2 ZNF654

3.71e-0431212CID000037723
Drugleucine methyl ester

SMARCA2 ZNF654

5.01e-0436212CID000065105
Drug2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A_EA

MICAL3 CSPG5 POLR3G

6.91e-04191213994_UP
DrugGuanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A

SUPT5H SUPT6H ZNF654

6.91e-041912132634_DN
DrugTiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A

SMARCA2 SUPT6H CEP152

7.02e-041922132292_DN
DrugCaffeic acid [3331-39-5]; Down 200; 22.2uM; PC3; HT_HG-U133A

GTF2A1 SUPT6H APLP2

7.13e-041932136753_DN
DrugGlafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; MCF7; HT_HG-U133A

ZNF330 CSPG5 POLR3G

7.13e-041932137418_DN
DrugCarbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A

SUPT6H MICAL3 CEP152

7.13e-041932131805_DN
DrugTranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; HL60; HG-U133A

SMARCA2 APLP2 POLR3G

7.13e-041932131417_DN
DrugAcenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A

GTF2A1 SUPT6H CEP152

7.13e-041932137232_DN
DrugTrichlorfon [52-68-6]; Down 200; 15.6uM; MCF7; HT_HG-U133A

SMARCA2 SUPT6H CEP152

7.23e-041942131675_DN
DrugBuflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A

SMARCA2 MICAL3 CEP152

7.23e-041942133274_DN
DrugBromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A

SMARCA2 SUPT6H TRIM52

7.23e-041942137457_DN
DrugAndrosterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A

ZNF330 CSPG5 POLR3G

7.23e-041942132650_DN
DrugIfenprodil tartrate [23210-58-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A

SMARCA2 GTF2A1 POLR3G

7.34e-041952137404_DN
DrugDL-PPMP; Down 200; 2uM; MCF7; HT_HG-U133A_EA

SUPT5H ZNF654 TRIM52

7.34e-041952131121_DN
DrugTolbutamide [64-77-7]; Down 200; 14.8uM; HL60; HT_HG-U133A

SMARCA2 ZNF654 POLR3G

7.34e-041952132359_DN
DrugHydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A

ZNF330 SUPT6H CSPG5

7.34e-041952131687_DN
DrugTriprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A

ZNF330 GTF2A1 POLR3G

7.34e-041952137408_DN
DrugHomosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A

SMARCA2 SUPT6H APLP2

7.34e-041952134533_DN
DrugDiphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A

SMARCA2 SUPT6H POLR3G

7.45e-041962131708_DN
DrugDoxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A

GTF2A1 SUPT6H MICAL3

7.45e-041962134819_DN
DrugDyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A

ZNF654 TRIM52 CEP152

7.45e-041962137022_DN
DrugFlutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A

GTF2A1 SUPT6H MICAL3

7.45e-041962134539_DN
DrugAntipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A

SMARCA2 MICAL3 CSPG5

7.45e-041962131497_UP
DrugDosulepin hydrochloride [897-15-4]; Up 200; 12uM; HL60; HG-U133A

APLP2 ZNF654 CEP152

7.45e-041962131713_UP
Drug6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A

SMARCA2 SUPT6H ZNF654

7.45e-041962134833_UP
DrugCalycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A

SMARCA2 SUPT5H CEP152

7.45e-041962132764_DN
DrugPiromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A

SMARCA2 SUPT6H CEP152

7.56e-041972133335_DN
Drugnordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA

GTF2A1 CEP152 PLCE1

7.56e-041972131003_UP
Drug(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A

SMARCA2 GTF2A1 CEP152

7.56e-041972134363_DN
DrugAlclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; HL60; HT_HG-U133A

CSPG5 PLCE1 POLR3G

7.56e-041972132532_DN
DrugPanthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A

SMARCA2 SUPT6H POLR3G

7.56e-041972131680_DN
DrugSB 202190; Down 200; 1uM; MCF7; HT_HG-U133A

ZNF654 MICAL3 CEP152

7.56e-041972136909_DN
DrugMesalamine [89-57-6]; Down 200; 26.2uM; MCF7; HT_HG-U133A

SUPT6H MICAL3 CEP152

7.56e-041972137241_DN
DrugProadifen hydrochloride [62-68-0]; Down 200; 10.2uM; PC3; HT_HG-U133A

SUPT6H ZNF654 CEP152

7.68e-041982135807_DN
DrugCimetidine [51481-61-9]; Up 200; 15.8uM; MCF7; HT_HG-U133A

ZNF330 SUPT6H CEP152

7.68e-041982131464_UP
DrugSR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A

SMARCA2 GTF2A1 SUPT6H

7.68e-041982134977_UP
DrugAcetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; HL60; HG-U133A

ZNF330 SUPT6H CEP152

7.68e-041982131377_UP
DrugBambuterol hydrochloride [81732-46-9]; Down 200; 10uM; PC3; HT_HG-U133A

SUPT5H SUPT6H CEP152

7.68e-041982135885_DN
DrugMesoridazine besylate [32672-69-8]; Up 200; 7.4uM; PC3; HT_HG-U133A

SMARCA2 SUPT6H CSPG5

7.68e-041982137256_UP
DrugST021200; Down 200; 10uM; MCF7; HT_HG-U133A

ZNF330 GTF2A1 POLR3G

7.68e-041982137554_DN
DrugCephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A

SMARCA2 APLP2 MICAL3

7.68e-041982133258_UP
DrugGSK-3 Inhibitor IX; Down 200; 0.5uM; MCF7; HT_HG-U133A

SMARCA2 SUPT6H MICAL3

7.68e-041982136589_DN
DrugAmodiaquin dihydrochloride dihydrate [6398-98-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A

SMARCA2 SUPT5H SUPT6H

7.68e-041982136224_DN
DrugMilrinone [78415-72-2]; Down 200; 19uM; PC3; HT_HG-U133A

ZNF330 SUPT6H MICAL3

7.79e-041992135856_DN
DrugViomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A

SMARCA2 GTF2A1 SUPT6H

7.79e-041992133541_UP
DrugUngerine nitrate; Down 200; 10.2uM; MCF7; HT_HG-U133A

SMARCA2 SUPT6H TRIM52

7.79e-041992137173_DN
DrugBenzathine benzylpenicillin [5928-84-7]; Down 200; 4.2uM; MCF7; HT_HG-U133A

GTF2A1 ZNF654 POLR3G

7.79e-041992134140_DN
DrugMoxonidine [75438-57-2]; Down 200; 16.6uM; MCF7; HT_HG-U133A

SUPT6H CEP152 POLR3G

7.79e-041992137343_DN
DrugDebrisoquin sulfate [581-88-4]; Down 200; 9uM; MCF7; HT_HG-U133A

SMARCA2 CEP152 CSPG5

7.79e-041992135288_DN
DrugLymecycline [992-21-2]; Down 200; 6.6uM; PC3; HT_HG-U133A

SMARCA2 SUPT6H CEP152

7.90e-042002137291_DN
DrugFlorfenicol [73231-34-2]; Up 200; 11.2uM; PC3; HT_HG-U133A

SMARCA2 GTF2A1 APLP2

7.90e-042002136701_UP
DrugPicotamide monohydrate [80530-63-8]; Up 200; 10.2uM; HL60; HG-U133A

SMARCA2 SUPT6H POLR3G

7.90e-042002131387_UP
Diseasegastric carcinoma

SMARCA2 PLCE1

1.65e-0389202EFO_0000178
Diseasedyslexia

SMARCA2 CREBRF

5.33e-03162202EFO_0005424
Diseasenon-high density lipoprotein cholesterol measurement

APLP2 SPTY2D1 PLCE1

1.18e-02713203EFO_0005689

Protein segments in the cluster

PeptideGeneStartEntry
DEEYDEEDYEREKEL

CEP152

16

O94986
FYDDLDEEEEEEEDD

CSPG5

271

O95196
ENEEEEEEEEDYEDD

CREBRF

381

Q8IUR6
EEEEEDYEDDKDDDI

CREBRF

386

Q8IUR6
EEEEEEEDEEEDYDV

APLP2

221

Q06481
NEEEEEEEEEYEEEE

MICAL3

991

Q7RTP6
EEEEEYEEEEEEDYD

MICAL3

996

Q7RTP6
YEEEEEEDYDEEEEE

MICAL3

1001

Q7RTP6
DDYDEEDEDEVEEEE

GPIHBP1

36

Q8IV16
EEEDFEEEEEDEEEY

PELP1

906

Q8IZL8
EEEEEDEEEYFEEEE

PELP1

911

Q8IZL8
DEEEYFEEEEEEEEE

PELP1

916

Q8IZL8
EEEEKEEEEEEEYDE

POLR3GL

171

Q9BT43
EEEEEEEYDEEEHEE

POLR3GL

176

Q9BT43
EEYDEEEHEEETDYI

POLR3GL

181

Q9BT43
DYVWEEEDEEEDLDY

TRIM41

121

Q8WV44
EESDSDYEEEDEEEE

SMARCA2

636

P51531
EEEDEEDEYDYDYES

PLCE1

1581

Q9P212
EEEYDEEEEEEDDDR

SUPT5H

51

O00267
EYEEEDDDDDEYDSE

SPTY2D1

586

Q68D10
EYDEELEEEYEYEDD

SUPT6H

231

Q7KZ85
DEEEDYDDDEEEDKE

GTF2A1

286

P52655
WDEEEEEEEEDQDYY

TRIM52

121

Q96A61
EEEEDEEGDYEEDDY

ZNF654

701

Q8IZM8
EEYDEEEQEEENDYI

POLR3G

186

O15318
EEEEEEEEEYEQDER

YTHDC1

241

Q96MU7
EEDEYEAEDDEEEED

ZNF330

271

Q9Y3S2
YYIYEEEEEEEEEEE

STAC3

61

Q96MF2